Neurological Complications of Biological Treatment of Psoriasis
In the available literature, little attention has been paid to the assessment of psoriasis and the biological therapy used for it and the nervous system. The purpose of this article is to discuss the relationship between psoriasis and the nervous system as well as to analyze the mechanisms that lead...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/1/118 |
_version_ | 1797492640263962624 |
---|---|
author | Mateusz Kamil Ożóg Beniamin Oskar Grabarek Magdalena Wierzbik-Strońska Magdalena Świder |
author_facet | Mateusz Kamil Ożóg Beniamin Oskar Grabarek Magdalena Wierzbik-Strońska Magdalena Świder |
author_sort | Mateusz Kamil Ożóg |
collection | DOAJ |
description | In the available literature, little attention has been paid to the assessment of psoriasis and the biological therapy used for it and the nervous system. The purpose of this article is to discuss the relationship between psoriasis and the nervous system as well as to analyze the mechanisms that lead to neurological complications during anticytokine therapies in psoriasis. However, this connection requires further analysis. The use of biological drugs in psoriasis, although it yields positive therapeutic results, is not without numerous side effects. Serious neurological side effects of the therapy are most often visible with the use of anti-TNF-alpha, which is why patients should be monitored for their potential occurrence. Early detection of complications and rapid discontinuation of treatment with the drug may potentially increase the patient’s chances of a full recovery or improvement of his/her neurological condition. It also seems reasonable that, in the case of complications occurring during anti-TNF-alpha therapy, some of the drugs from other groups should be included in the therapy. |
first_indexed | 2024-03-10T01:06:37Z |
format | Article |
id | doaj.art-961021d4aa3f46278aa6b4a221fb6a94 |
institution | Directory Open Access Journal |
issn | 2075-1729 |
language | English |
last_indexed | 2024-03-10T01:06:37Z |
publishDate | 2022-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Life |
spelling | doaj.art-961021d4aa3f46278aa6b4a221fb6a942023-11-23T14:25:19ZengMDPI AGLife2075-17292022-01-0112111810.3390/life12010118Neurological Complications of Biological Treatment of PsoriasisMateusz Kamil Ożóg0Beniamin Oskar Grabarek1Magdalena Wierzbik-Strońska2Magdalena Świder3Department of Histology, Cytophysiology and Embryology, Faculty of Medicine, University of Technology in Katowice, 41-800 Zabrze, PolandDepartment of Histology, Cytophysiology and Embryology, Faculty of Medicine, University of Technology in Katowice, 41-800 Zabrze, PolandFaculty of Medicine, University of Technology in Katowice, 41-800 Zabrze, PolandDepartment of Histology, Cytophysiology and Embryology, Faculty of Medicine, University of Technology in Katowice, 41-800 Zabrze, PolandIn the available literature, little attention has been paid to the assessment of psoriasis and the biological therapy used for it and the nervous system. The purpose of this article is to discuss the relationship between psoriasis and the nervous system as well as to analyze the mechanisms that lead to neurological complications during anticytokine therapies in psoriasis. However, this connection requires further analysis. The use of biological drugs in psoriasis, although it yields positive therapeutic results, is not without numerous side effects. Serious neurological side effects of the therapy are most often visible with the use of anti-TNF-alpha, which is why patients should be monitored for their potential occurrence. Early detection of complications and rapid discontinuation of treatment with the drug may potentially increase the patient’s chances of a full recovery or improvement of his/her neurological condition. It also seems reasonable that, in the case of complications occurring during anti-TNF-alpha therapy, some of the drugs from other groups should be included in the therapy.https://www.mdpi.com/2075-1729/12/1/118psoriasisbiological treatmentanticytokine therapytumor necrosis factor alphanervous systemside effects |
spellingShingle | Mateusz Kamil Ożóg Beniamin Oskar Grabarek Magdalena Wierzbik-Strońska Magdalena Świder Neurological Complications of Biological Treatment of Psoriasis Life psoriasis biological treatment anticytokine therapy tumor necrosis factor alpha nervous system side effects |
title | Neurological Complications of Biological Treatment of Psoriasis |
title_full | Neurological Complications of Biological Treatment of Psoriasis |
title_fullStr | Neurological Complications of Biological Treatment of Psoriasis |
title_full_unstemmed | Neurological Complications of Biological Treatment of Psoriasis |
title_short | Neurological Complications of Biological Treatment of Psoriasis |
title_sort | neurological complications of biological treatment of psoriasis |
topic | psoriasis biological treatment anticytokine therapy tumor necrosis factor alpha nervous system side effects |
url | https://www.mdpi.com/2075-1729/12/1/118 |
work_keys_str_mv | AT mateuszkamilozog neurologicalcomplicationsofbiologicaltreatmentofpsoriasis AT beniaminoskargrabarek neurologicalcomplicationsofbiologicaltreatmentofpsoriasis AT magdalenawierzbikstronska neurologicalcomplicationsofbiologicaltreatmentofpsoriasis AT magdalenaswider neurologicalcomplicationsofbiologicaltreatmentofpsoriasis |